MERCK Kommanditgesellschaft auf Aktien operates in the healthcare, life science, and electronics sectors worldwide. It discovers, develops, manufactures, and markets pharmaceutical and biological prescription drugs to treat neurology and immunology, oncology, fertility, and cardiology metabolism and endocrinology. The company also supplies products, tools, and services for research laboratories, pharma and biotech production, and industrial and testing laboratories. In addition, it offers material for integrated circuits, liquid crystals, organic light-emitting diodes, photoresists, smart antenna, and liquid crystal glazing solutions, as well as effect pigments for use in automotive coatings, cosmetics, industrial, and plastic applications. It has strategic alliances with Pfizer Inc.; agreement with Novartis AG; and license agreements with Debiopharm International SA and MoonLake Immunotherapeutics AG. The company was founded in 1668 and is headquartered in Darmstadt, Germany. MERCK Kommanditgesellschaft auf Aktien is a subsidiary of E. Merck Kommanditgesellschaft.

MERCK Kommanditgesellschaft auf Aktien

Grünenthal is a science-based, privately-owned pharmaceutical company focused on pain management and related diseases.

Grünenthal

Helm AG is a global chemical-logistic company.

Helm AG

Hera BioLabs provides preclinical research services with a focus on gene editing. The company offers proprietary platforms and custom research models to support drug discovery and development.

Metric
Company Name	MERCK Kommanditgesellschaft auf Aktien	Grünenthal	Helm AG	Hera BioLabs
Symbol	MRK
MSH ID	COM:MERCKGROUP	COM:GRUNENTHAL	COM:HELM-NAGEL	COM:HERABIOLABS
Market	STOCKS	PRIVATE	PRIVATE	PRIVATE
Sector	Healthcare	Healthcare & Health Services	Commercial & Professional Services	Healthcare & Health Services
Industry	Drug Manufacturers - Specialty & Generic	Pharmaceuticals	Logistics and Supply Chain	Biotechnology
Country	DE	DE	DE	US
Stage				Venture Round
Employee Count	62.34K
Website	merckgroup.com	grunenthal.com	helm-nagel.com	herabiolabs.com
LinkedIn			helm-&-nagel-gmbh
Founders

Metric
Market Cap	68.68B
Enterprise Value
Monthly Web Traffic	1.20M	1.41K
Web Traffic Growth	0.02	-0.46
Valuation
Raised Capital	2.77M	1.07M

Metric
Revenue	22.17B
Revenue (LTM)
Revenue (NTM)
Gross Profit	12.33B
EBITDA	6.15B
Operating Income	4.27B
Net Income	2.98B
EPS	6.87
Diluted EPS	6.87
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin	0.59
Operating Profit Margin	0.19
EBITDA Margin	0.28
Net Profit Margin	0.13
Return on Equity	0.10
Return on Assets	0.06
Return on Capital Employed	0.10

COM:MERCKGROUP

Merck

Last Close

141.75

25/11 09:24

Market Cap

65.02B

Beta: -

Volume Today

20.79K

Avg: -

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio	22.33
P/B Ratio	2.29
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio	3.64
EV Multiple	11.50

Metric
Days Sales Outstanding	82.97
Days Payables Outstanding	95.71
Days Inventory Outstanding	197.34
Operating Cycle	282.62
Cash Conversion Cycle	193.24
Asset Turnover	0.43

Metric
Operating Cash Flow	4.00B
Free Cash Flow	-774.22M
Cash Flow to Debt	0.41
Operating Cash Flow/Sales	0.20
Free Cash Flow Yield	0.03

Metric
Cash & Equivalents	2.09B
Accounts Receivable	-8.45M
Inventory	4.90B
Goodwill	18.85B
Debt to Capitalization	0.26
Debt to Assets	0.22
Current Ratio	1.56
Quick Ratio	0.84

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue	0.12
SG&A to Revenue	0.06